Clinical Trial Update: Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness of Iguratimod versus placebo for early rheumatoid arthritis using MRI outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN